The dermal filler market has seen considerable growth due to a variety of factors.
• The market size for dermal fillers has seen a quick expansion in the past few years. The projected growth is from $6.57 billion in 2024 to $7.24 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.2%.
Factors contributing to this surge during the historical period include the growth of the aesthetic industry, improved injection techniques, the impact and endorsement from celebrities, the emphasis on anti-aging treatments, and an increase in minimally invasive procedures.
The dermal filler market is expected to maintain its strong growth trajectory in upcoming years.
• The size of the dermal filler market is anticipated to witness substantial growth in the coming years. It is projected to expand to $11.13 billion by 2029, with a compound annual growth rate (CAGR) of 11.3%.
The expected growth during the forecast period is due to factors such as market development in developing countries, tailored and individualized treatments, and the use of biodegradable and bioabsorbable fillers, with an emphasis on enduring and durable results. Key trends for the forecast period encompass biodegradable fillers, sophisticated formulations, non-surgical procedures, adjustable treatments, and results with greater longevity.
The acceleration in the dermal filler market is predicted to be driven by a rise in the number of cosmetic procedures performed by plastic surgeons. Cosmetic procedures are treatments designed to enhance the appearance of the face and body. The importance of physical beauty and body image for personal identity and expression has been increasing. Dermal fillers are predominantly used in plastic or cosmetic surgery to achieve a fuller, smoother facial look. For example, a report by the Aesthetic Society, a professional organization based in the U.S., revealed that in 2023, the number of procedures for removing breast implant rose to 74,326, a significant leap from 65,076 in 2022, showing an increase of 14.2%. Consequently, the surge in the number of cosmetic procedures carried out by plastic surgeons boosts the expansion of the dermal filler market.
The dermal filler market covered in this report is segmented –
1) By Filler Type: Calcium Hydroxylapatite, Hyaluronic Acid, Poly-Alkylimide, Polylactic Acid, Polymethylmethacrylate Microspheres
2) By Product: Biodegradable, Non-Biodegradable
3) By Application: Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration Of Volume Or Fullness
4) By End-User: Hospital, Cosmetic Clinics, Outpatient Centers, Beauty Centers, Other End Users
Subsegments:
1) By Calcium Hydroxylapatite: Injectable Gels, Micro-spheres
2) By Hyaluronic Acid: Cross-linked Hyaluronic Acid, Non-cross-linked Hyaluronic Acid
3) By Poly-Alkylimide: Injectable Gels, Implantable Fillers
4) By Polylactic Acid: Injectable Solutions, Biodegradable Fillers
5) By Polymethylmethacrylate (PMMA) Microspheres: Injectable Suspensions, Semi-permanent Fillers
Key players in the dermal filler industry are attempting to enhance market growth by developing cutting-edge formulas such as undereye dermal fillers using hyaluronic acid (HA). These dermal fillers are injectable, gel-like treatments aimed at restoring volume, reducing hollowness and lessening dark circles under the eyes using hyaluronic acid for improved hydration and a natural look. For example, Galderma, a dermatology company based in Switzerland, introduced Restylane Eyelight, the first-of-its-kind hyaluronic acid (HA) dermal filler in the U.S. that incorporates NASHA Technology in June 2023. The effects of the Restylane Eyelight, which has minimal crosslinking and a moisture-resistant gel texture for a more natural look, can endure up to 18 months. A Phase 3 clinical trial confirmed that, after three months, 87% of patients noted a decrease in under-eye hollowness, and satisfaction rates remained high over a year.
Major companies operating in the dermal filler market include:
• Merz Pharma GmbH & Co. KGaA
• Laboratoires Vivacy
• Bloomage Biotechnology Corporation Limited
• Teoxane Laboratories
• Sinclair Pharma
• Anika Therapeutics Inc.
• Croma-Pharma GmbH
• Revance Therapeutics Inc.
• BioPlus Co. Ltd.
• Hans Biomed Corp.
• Regen Lab SA
• Prollenium Medical Technologies Inc.
• Scivision Biotech Inc
• Hyaltech Ltd.
• Bioxis Pharmaceuticals
• Suneva Medical Inc.
• Bohus BioTech AB
• Medy Tox Inc
• Galderma S.A.
• Sculpt Fillers
• Sylagen
North America was the largest region in the dermal filler market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermal filler market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.